248
Participants
Start Date
August 31, 2020
Primary Completion Date
March 8, 2022
Study Completion Date
March 8, 2022
Cotadutide 100 micrograms
Cotadutide 100 micrograms administered subcutaneously
Cotadutide 300 micrograms
Cotadutide 300 micrograms administered subcutaneously
Cotadutide 600 micrograms
Cotadutide 600 micrograms administered subcutaneously
Semaglutide
Semaglutide 1.0 miligrams administered subcutaneously
Placebo
Placebo administered subcutaneously
Research Site, Grafton
Research Site, Auckland
Research Site, Merewether
Research Site, Wollongong
Research Site, Melbourne
Research Site, Fitzroy
Research Site, Heidelberg
Research Site, Tauranga
Research Site, Box Hill
Research Site, Woolloongabba
Research Site, Havelock North
Research Site, New Plymouth
Research Site, Oaklands Park
Research Site, Elizabeth Vale
Research Site, Wellington
Research Site, Christchurch
Research Site, Berlin
Research Site, Berlin
Research Site, Berlin
Research Site, Córdoba
Research Site, A Coruña
Research Site, Lublin
Research Site, Lleida
Research Site, Madrid
Research Site, Majadahonda
Research Site, Pozuelo de Alarcón
Research Site, Málaga
Research Site, Kassel
Research Site, Magdeburg
Research Site, Düsseldorf
Research Site, Seville
Research Site, Seville
Research Site, Dortmund
Research Site, Essen
Research Site, Valencia
Research Site, Münster
Research Site, Münster
Research Site, Mainz
Research Site, Sankt Ingbert
Research Site, Ludwigshafen
Research Site, München
Research Site, Vancouver
Research Site, Barrie
Research Site, Brampton
Research Site, Concord
Research Site, Etobicoke
Research Site, Oakville
Research Site, Oshawa
Research Site, Ottawa
Research Site, Toronto
Research Site, Toronto
Research Site, Waterloo
Research Site, Laval
Research Site, Montreal
Research Site, Riesa
Research Site, Arakawa-ku
Research Site, Chitose-shi
Research Site, Fujisawa-shi
Research Site, Kamakura-shi
Research Site, Obihiro-shi
Research Site, Sapporo
Research Site, Shinjyuku-ku
Research Site, Auckland
Research Site, Bialystok
Research Site, Grodzisk Mazowiecki
Research Site, Katowice
Research Site, Krakow
Research Site, Krakow
Research Site, Krakow
Research Site, Poznan
Research Site, Skierniewice
Research Site, Warsaw
Research Site, Warsaw
Research Site, Warsaw
Research Site, Wierzchosławice
Research Site, Barcelona
Research Site, L'Hospitalet de Llobregat
Research Site, Palma
Research Site, Palma de Mallorca
Research Site, Vitoria-Gasteiz
Research Site, Dundee
Research Site, Liverpool
Research Site, London
Lead Sponsor
AstraZeneca
INDUSTRY